AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04880785 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dolutegravir 50 MG / Lamivudine 300 MG Oral Tablet [Dovato]
Description: change of current antiretroviral treatment to DTG 50 mg/3TC 300 mg QD
Study NCT06288620 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Microwave Ablation
Description: Preoperative US-guided microwave ablation of breast cancer
Study NCT05929716 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Magrolimab
Description: Given by IV (vein)
Study NCT05929716 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: Given by IV (vein)
Study NCT05929716 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CAR T leukapheresis
Description: Given by IV (vein)
Study NCT05929716 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Radiation
Description: Given by IV (vein)
Study NCT05470920 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Electronic Decision Aid
Description: Decision aid followed by an appointment with an oncologist. Will complete surveys/questionnaires
Study NCT05470920 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Pre-Test Genetic Counseling
Description: Receive pretest counseling with a genetic counselor. Will complete surveys/questionnaires
Study NCT04027699 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Mini-bolus
Description: * First injection of 2ml/kg (saline solution)~* Second injection of 18ml/kg (saline solution)
Study NCT05952440 — intervention group
Intervention type: OTHER
Intervention: Tapering and/or discontinuation of treatment based on AI-guidance
Description: After synovial tissue biopsy, pharmacological treatment (cDMARDs or bDMARDs) are tapered first and then bDMARDs and/or cDMARDs are discontinued based on AI-guidance
Study NCT05952440 — intervention group
Intervention type: OTHER
Intervention: No tapering and/or discontinuation of treatment based on AI-guidance
Description: Ongoing therapeutic are not changed (tapered or discontinued) after synovial biopsy performance based on AI-guidance
Study NCT05952440 — intervention group
Intervention type: OTHER
Intervention: Tapering and/or discontinuation of treatment based on standard of care
Description: After synovial tissue biopsy, pharmacological treatment (cDMARDs or bDMARDs) are tapered first and then bDMARDs and/or cDMARDs are discontinued based on standard of care
Study NCT05952440 — intervention group
Intervention type: OTHER
Intervention: No tapering and/or discontinuation of treatment based on standard of care
Description: Ongoing therapeutic are not changed (tapered or discontinued) after synovial biopsy performance based on standard of care
Study NCT06186076 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TRX-221
Description: TRX-221 oral dose as defined
Study NCT06460675 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Autogenic Inhibition Muscle Energy Technique
Description: No of repetitions: 1 set with 3 repetitions No of Sessions per week: 2 per weeks for 3 weeks (40 Min per Session)
Study NCT06460675 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Autogenic Inhibition Muscle Energy Technique
Description: No of repetitions: 1 set with 3 repetitions No of Sessions per week: 2 per weeks for 3 weeks (40 Min per Session)
Study NCT06460675 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Reciprocal Inhibition Muscle Energy Technique
Description: No of repetitions: 1 set with 3 repetitions No of Sessions per week: 2 per week for 3 weeks (40 Min per Session)
Study NCT06460675 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Reciprocal Inhibition Muscle Energy Technique
Description: No of repetitions: 1 set with 3 repetitions No of Sessions per week: 2 per week for 3 weeks (40 Min per Session)
Study NCT05442255 — intervention group
Intervention type: OTHER
Intervention: Toxicological analysis
Description: Automated enzymatic assays Automated Immunoassay Urine Screening High Resolution Toxicological Screening
Study NCT04778436 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: T7082
Description: Patients will take food supplementation for 12 months. For each patient : 5 visits with ophthalmogist and 6 phone call
Study NCT04800562 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PCS499
Description: PCS499 900mg twice a day with food
Study NCT04800562 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo comparator
Study NCT04945668 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Modified technique for pericapsular nerve group block
Description: with the patient in the supine position, ultrasound probe in a transverse plane over the anterior inferior iliac spine (AIIS) and then aligned with the pubic ramus. In this view, the ilio pubic eminence (IPE), the iliopsoas muscle and tendon will be observed. A spinal needle will be inserted from lateral to medial in an in-plane approach to place the tip between the psoas tendon and the pubic ramus. Fluoroscopic image will be taken to confirm the needle tip position in the target site. Following negative aspiration, 15 ml dye will be injected in 5-mL increments while observing for adequate spread using fluoroscopy followed by 15ml local anesthetic
Study NCT04986306 — intervention group
Intervention type: PROCEDURE
Intervention: SLNB + ALND
Description: Patients who received neoadjuvant chemotherapy will undergo SLNB+ALND to evaluate the feasibility of SLNB
Study NCT05155202 — intervention group
Intervention type: DRUG
Intervention: Antihypertensive Agents
Description: Administration of intravenous Nicardipine or Urapidil
Study NCT06147479 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CS-ADL (Cognitive stimulation in Activities of Daily Living)
Description: CS-ADL sessions are delivered once weekly, for seven weeks. Sessions last approximately 2 hours. Sessions are themed around domains of everyday activities, for example 'Morning routine', ' Domestic Activities', 'Leisure'. Activities in each session follow this theme. A typical session begins with introductions, reality orientation, a group song and discussion of the news of the week. This is followed by a physical activity/game and ADL-focused cognitive stimulation activities. These activities include the identification and categorization of everyday items, discussion, reminiscence, planning and sequencing of ADLs and the completion of everyday writing/calculation tasks. This is followed by practice of an ADL. Examples of activities include making a breakfast, a simple gardening activity or sorting laundry. The session then ends with a summary and repeat of the group song, and a plan for the next session.
Study NCT05071365 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Early access to virtual resources
Description: Single arm study. Participants are given access to self help videos for the management of plantar fasciitis while they are on the waiting list
Study NCT04750876 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional support
Description: Patients in the Conventional support randomisation arm will follow the usual care of amputee patients in the vascular surgery department. They will be cared for by the surgeon, nurses and nursing auxiliaries, who will provide individualised care (nursing care, mobilisation, pain management, technical care, etc.), listening and support.
Study NCT04750876 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Specific care, including the intervention of a psychologist and a physical therapist.
Description: In the case where the patient is in the Specific care, including the intervention of a psychologist and a physical therapist. arm, the usual care will be associated with :~* consultations with a psychologist~* The patient will also be cared for on a daily basis by a physical therapist.
Study NCT05539768 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HS-IT101
Description: Adoptive transfer of 1x10\^9-6x10\^10 autologous TIL to patients i.v. in 30-60 minutes.
Study NCT05863104 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Glycopyrronium Bromide (GPB) Cream
Description: Application of cream to each axilla
Study NCT06369103 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine
Description: Patients will receive dexmedetomidine at a dose of 0.5-1.0 mcg/kg over 5-10 minutes, then a maintenance infusion rate of 0.2-0.5 mcg/kg/min when the bispectral index (BIS) value is between 70 and 80.
Study NCT06369103 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol
Description: Patients will receive propofol at a dose of 0.25-0.5 mg/kg over 5-10 minutes, then a maintenance Infusion rate of 0.5-2 mg/kg/hr when the bispectral index (BIS) value is between 70 and 80.
Study NCT05287945 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Orellanine
Description: Orellanine administered intravenously
Study NCT05094791 — intervention group
Intervention type: DEVICE
Intervention: Telescoping Lag Screw
Description: Intertrochanteric fracture fixation using Arthrex Hip Nail with Telescoping Lag Screw
Study NCT05094791 — intervention group
Intervention type: DEVICE
Intervention: Standard lag Screw
Description: Intertrochanteric fracture fixation using Zimmer Natural Nail Cephalomedullary Nail using standard lag screw
Study NCT05094791 — intervention group
Intervention type: DEVICE
Intervention: Standard lag screw with addition of worm screw
Description: Intertrochanteric fracture fixation using Smith and Nephew TRIGEN INTERTAN with addition of worm screw
Study NCT05353699 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Implementation strategies
Description: We will adopt implementation strategies,which include Capacity-building strategies, Supervision, Integration strategies, Implementation process strategies, Dissemination strategies, Scale-up strategies.Firstly,Capacity-building strategies include:recruit, designate, and train for leadership; work with educational institutions.Secondly,Supervision includes provide clinical supervision;Thirdly,Integration strategies include: remind clinicians; use data warehousing techniques.Fourthly,Implementation process strategies include: identify and prepare champions; identify early adopters; inform local opinion leaders; involve patients/consumers and family members; obtain and use patients/consumers and family feedback.Fifthly,Dissemination strategies include: make training dynamic.Finally,Scale-up strategies include: use train-the-trainer strategies;place innovation on fee for service lists/formularies.
Study NCT04790136 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GLA-015
Description: administration followed by PK blood sampling
Study NCT04790136 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: DAC C-052 Cannabidiol / NRF 22.10 Oily cannabidiol solution 100 mg/ml
Description: administration followed by PK blood sampling
Study NCT05377788 — intervention group
Intervention type: DRUG
Intervention: Lazertinib
Description: Treatment of EGFR T790M mutant-positive local progressive or metastatic non-small cell lung cancer patients who have previously been treated with EGFR
Study NCT05439161 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: surgery
Description: 2 types of filtering glaucoma surgeries (classic trabeculectomy as gold standard, and newer XEN glaucoma microstent) are compared against each other in a prospective multicentric randomized study
Study NCT05732090 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: therapeutic exercise program
Description: therapeutic exercise program (3 sessions/week/two months).
Study NCT05732090 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: diaphragmatic myofascial release
Description: therapeutic exercise program in addition to diaphragmatic myofascial release (3 sessions/week/two months).
Study NCT05689970 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: AI platform to detect ST elevation in ECG
Description: A clinical decision support software as a medical device that detects whether a patient has ST elevation due to acute myocardial ischemia or due to another etiology based upon the input of one or more ECGs and other clinical data obtained at the point-of-care.
Study NCT06466629 — intervention group
Intervention type: BIOLOGICAL
Intervention: Triaxis, Sanofi Pasteur
Description: tetanus, diphtheria, acellular pertussis (aP) (Tdap) vaccine
Study NCT04046107 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cemiplimab
Description: Administered as an intravenous (IV) infusion
Study NCT05121480 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EDP1815
Description: EDP1815 is an orally administered, pharmaceutical preparation of a single strain of bacteria
Study NCT05121480 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo oral capsule
Study NCT01093274 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sodium Picosulphate
Description: 2 Sachets
Study NCT01093274 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Polyethylene Glycol
Description: 3 Liters solution
Study NCT05894174 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Board Game
Description: Food Hunter board game intervention, which includes various nutrient cards and question cards and is played with pawns and dice, will be played with children for approximately 4 weeks, one day a week and one session (40 minutes) with the researcher dietitian. By talking about the nutrients in the game on the game cards, children will be able to recognize the nutrients and important points will be emphasized for the participants with the answers to the cards containing various questions about healthy nutrition.
Study NCT06319313 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JMT101
Description: JMT101, 6 mg/kg, IV infusion once every 2 weeks (one treatment cycle is 4 weeks). or 9 mg/kg, IV infusion once every 3 weeks.
Study NCT06319313 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: docetaxel
Description: 50 mg/m2, IV infusion once every 2 weeks (one treatment cycle is 4 weeks). Or 75 mg/m2, IV infusion once every 3 weeks.
Study NCT06319313 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HB1801
Description: 75 mg/m2, IV infusion once every 2 weeks (one treatment cycle is 4 weeks). Or 100 mg/m2, IV infusion once every 3 weeks.
Study NCT05137548 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATI-2173 50 mg
Description: ATI-2173 is a liver-targeted phosphoramidate oral prodrug of clevudine designed to enhance anti-HBV activity while decreasing systemic exposure to clevudine. It will be dosed as a capsule by mouth
Study NCT05137548 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tenofovir 300Mg Oral Tablet
Description: Tenofovir is an oral nucleotide analogue reverse transcriptase inhibitor used for chronic hepatitis B virus. It will be dosed as a tablet by mouth
Study NCT04854434 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Selinexor
Description: Participants will receive selinexor oral tablets.
Study NCT04854434 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Participants will receive pembrolizumab intravenously.
Study NCT04854434 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Trifluridine
Description: Participants will receive trifluridine oral tablets as SOC.
Study NCT04854434 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tipiracil
Description: Participants will receive tipiracil oral tablets as SOC.
Study NCT05371977 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Trabeculectomy
Description: trabeculectomy glaucoma surgery
Study NCT05371977 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Deep Sclerectomy
Description: deep sclerectomy glaucoma surgery
Study NCT05138016 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Soft exosuit
Description: Progressive cardiovascular exercise testing with soft exosuit assistance.
Study NCT05138016 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: No Soft exosuit
Description: Progressive cardiovascular exercise testing.
Study NCT05352815 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IcoSema
Description: Participants will receive once weekly IcoSema subcutanously (s.c. under the skin) with or without oral anti diabetic drugs for 52 weeks.
Study NCT05352815 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin icodec
Description: Participants will receive once weekly Insulin icodec subcutanously (s.c. under the skin) with or without oral anti diabetic drugs for 52 weeks.
Study NCT06490640 — intervention group
Intervention type: OTHER
Intervention: Spontaneous subarachnoid haemorrhage survival cohort
Description: consists of surviving patients
Study NCT06490640 — intervention group
Intervention type: OTHER
Intervention: Spontaneous subarachnoid haemorrhage mortality cohort
Description: consists of deceased patients
Study NCT04461262 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Camstent Coated Catheter
Description: The patented 'M4D coating' is applied to inner and outer surfaces using a 'dip/dry' process before sterilisation, creating a safe, inert, and long-lasting finish. The coating reduces friction of the catheter surface, enhancing patient comfort on insertion and withdrawal. It also incorporates the materials which virtually preclude biofilm formation. The coating doesn't elute antibacterial agents or toxins, avoiding the build-up of dead bacteria on the device surface and retaining effectiveness throughout extended use (NB. Effectiveness is not lost because of leaching away of an active antimicrobial agent). Finally, the absence of anti-bacterial moieties means that the healthy microbial flora is not disturbed. The device is CE marked
Study NCT04461262 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Standard Care
Description: Uncoated Foley catheter
Study NCT04654442 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: TestNPass
Description: Patients will undergo saliva sampling. Grenoble University Hospital lab will perform diagnosis using TestNPass IVDMD. Results won't be used for patient care (only recorded for RESEARCH purpose).
Study NCT04725695 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Viscous Lidocaine
Description: The patients will be randomized to either viscous lidocaine or placebo
Study NCT04725695 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Viscous Lidocaine
Description: The patients will be randomized to either viscous lidocaine or placebo
Study NCT05224063 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Individualized CEN-targeted rTMS
Description: Delivers patterned magnetic stimulation based on individualized CEN targeting
Study NCT05224063 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Neuronavigated rTMS
Description: Delivers patterned magnetic stimulation based on MRI images
Study NCT05224063 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Scalp-targeted rTMS
Description: Delivers patterned magnetic stimulation based on BEAM F3 targeting
Study NCT05224063 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham rTMS
Description: Delivers placebo magnetic stimulation
Study NCT05224063 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Sham rTMS
Description: Delivers placebo magnetic stimulation
Study NCT05224063 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham rTMS
Description: Delivers placebo magnetic stimulation
Study NCT05923632 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dijital Game and Health Education
Description: After the children in the experimental group are informed about the digital game designed according to The The Information-Motivation-Behavioral Skills Model (IMB) in diabetes management, active participation of the children in the digital game will be ensured for 9 weeks; and participation status will be followed in the background of the game. At the end of 9 weeks, children will be asked to complete all stages of the game. Children who do not complete the game will be contacted once a week in line with their background follow-up and reminders will be made.
Study NCT06414525 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: abdominal massage
Description: It will include patients that will receive abdominal massage; the frequency and duration of the massage will be arranged as 3 sessions per week, with each session lasting an average of 20-25 minutes for 6 weeks.
Study NCT06414525 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: visceral manipulation
Description: It will include patients that will receive visceral manipulation; the frequency and duration of the technique will be arranged as 3 sessions per week, with each session lasting an average of 20-25 minutes for 6 weeks.
Study NCT06414525 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: instructions on daily, dietary , toilet , and physical activity habits
Description: It will include patients that will receive behavioral therapy: defecation mechanism and informing about negative attitudes and behaviors towards defecation), lifestyle advice (diet, water consumption, fiber food, etc.), teaching effective defecation posture, and timed toilet training.
Study NCT05307484 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Serious game
Description: This is a serious game in the form of a mobile application, designed to educate adults on dengue prevention.
Study NCT05307484 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dengue prevention website
Description: This is a website containing information regarding dengue prevention.